The mechanisms underlying disparate roles of the canonical Wnt signaling pathway in maintaining self-renewal or inducing differentiation and lineage specification in embryonic stem cells (ESCs) are not clear. In this study, we provide the first demonstration that self-renewal versus differentiation of human ESCs (hESCs) in response to Wnt signaling is predominantly determined by a two-layer regulatory circuit involving b-catenin, E-cadherin, PI3K/Akt, and Slug in a timedependent manner. Short-term upregulation of b-catenin does not lead to the activation of Tcell factor (TCF)-eGFP Wnt reporter in hESCs. Instead, it enhances E-cadherin expression on the cell membrane, thereby enhancing hESC self-renewal through E-cadherin-associated PI3K/Akt signaling. Conversely, long-term Wnt activation or loss of E-cadherin intracellular b-catenin binding domain induces TCF-eGFP activity and promotes hESC differentiation through b-catenininduced upregulation of Slug. Enhanced expression of Slug leads to a further reduction of Ecadherin that serves as a b-catenin "sink" sequestering free cytoplasmic b-catenin. The formation of such a framework reinforces hESCs to switch from a state of temporal self-renewal associated with short-term Wnt/b-catenin activation to definitive differentiation. STEM CELLS
INTRODUCTION
Canonical Wnt/b-catenin signaling has been suggested to facilitate the self-renewal of mouse and human embryonic stem cells (ESCs) [1] [2] [3] [4] [5] [6] [7] [8] . It has also been shown to enhance reprogramming of somatic cells to pluripotent stem cells [9, 10] . However, the specific role of Wnt/b-catenin in ESCs remains unclear. A number of studies have yielded opposing results in that Wnt signaling stimulates ESC differentiation and lineage specification [11] [12] [13] [14] [15] [16] . How does one reconcile these seemingly disparate outcomes of one signaling pathway in ESCs?
The canonical Wnt signaling pathway is activated when a Wnt ligand protein binds to its receptors Frizzled and Lrp5/6, which leads to the inhibition of the GSK3b (Ser-Thr kinase glycogen synthase kinase 3b)-mediated degradation of b-catenin. This allows the cytoplasmic b-catenin accumulate and translocate into the nucleus where it interacts with the lymphoid enhancer factor and T-cell factor (LEF/TCF) transcriptional complexes [17] [18] [19] . Subsequently, this interaction induces or suppresses the expression of many specific downstream target genes, such as pluripotency gene Sox2, Nanog, Oct3/4, mesoderm gene Brachyury, cell adhesion molecule E-cadherin, and E-cadherin suppressors Snail and Slug [1, 20, 21] . The gene expression profiles and subsequent biological functions, however, seem to be cell type-and/or signaling network dependent [19] .
In addition to its pivotal role as a downstream effector of canonical Wnt signaling, bcatenin is also an essential structure adaptor. It was first discovered as a component of a mammalian cell adhesion complex linking to the cytoplasmic tail of E-cadherin to mediate cell-cell adhesion [22] . E-cadherin is a transmembrane glycoprotein that mediates calciumdependent, homophilic cell-cell adhesion in all epithelial tissues including ESCs [18] . With the exception of being a supplementary marker for
MATERIALS AND METHODS
hESCs Culture, GSK3 Inhibitors, Wnt3a Treatments, and Clonogenic Assays H1 and H9 hESC lines were obtained from Wicell and CA1 cell line was a gift from Dr. Nagy (Mount Sinai hospital, Toronto, Canada). All cell lines were approved for use by the local ethics board and the Stem Cell Oversight Committee of the Canadian Institutes of Health Research. Undifferentiated hESC were maintained under feeder-free conditions in mouse embryonic fibroblast-conditioned medium (MEFCM) supplemented with 12 ng/ml human recombinant basic fibroblast growth factor (bFGF, BD) as described previously [27, 28] . Chemical defined medium (CDM) supplemented with 1xB27, 1xITS-G, 1xNEAA, and 40 ng/ml bFGF [37] was used in the majority of experiments. The dosages of GSK3 inhibitor 6-bromoindirubin-3 0 -oxime BIO (Calbiochem, Darmstadt, Germany, http://www.emdmillipore.com/CA/en) used, after serial dilution, in MEFCM and CDM were 2.5 and 0.83 lM, respectively; CHIR99021 (Tocris Bioscience, Bristol, UK, http://www. tocris.com), 3-6 lM; Wnt3a (R&D Systems, Minneapolis, MN, http://www.rndsystems.com), 100-200 ng/ml; PI3K inhibitor LY294002 (Cell signaling, Beverly, MA, http://www.cellsignal. com), 5 lM; Akt activator II SC79 (EMD Millipore, Etobicoke, Canada, http://www.emdmillipore.com/CA/en) [38] , 4-6 lg/ ml; Akt inhibitor VIII (Cayman Chemical, Ann Arbor, MI, https://www.caymanchem.com), 3-6 lM; IWP2 (Cayman Chemical), 2 lM. Clonogenic and self-renewal assays were performed as described previously [27] . See Supporting Information for detailed procedures.
Plasmids Transfection and siRNA Knockdown
Plasmid hE-cadherin/Db-catenin-pcDNA3 (EcadDb), obtained from Addgene (Cambridge, MA, https://www.addgene.org) (#45772), was a kind gift from Dr. Barry Gumbiner [39] . This mutant does not contain a b-catenin binding region due to deletion of the last 35 amino acids of the E-cadherin cytoplasmic domain, as defined by Stappert and Kemler [40] . Plasmid pcDNA3-bS33Y Beta-catenin (bS33Y, Addgene #19286) [41] contains a tyrosine to serine missense mutation at codon 33 (S33Y, presumptive GSK3b phosphorylation site), leading to cellular accumulation and an ability to activate TCF transcription [41] . Other plasmids obtained from Addgene include hEcadherin-pcDNA3 (#45769) [39] , pLKO-siSlug3 (#10905) [42] , and pLKO-scrambled (#1864) [43] . See Supporting Information for siRNA targeted Slug and E-cadherin knockdown.
Generation of Tet-On Stable hESC Cell Lines
Stable E-cadherin-Tet-On and vector-Tet-On hESCs were generated from H9 and H1 hESCs as reported previously [28] . Stable EcadDb-Tet-On and bS33Y-Tet-On hESCs were generated using Lenti-X Tet-On advanced inducible expression system (Clontech, Mountain View, CA, http://www.clontech.com) according to the manufacturer's instructions [28] . EcadDb and bS33Y genes were amplified by PCR from hEcadDb-pcDNA3 and pcDNA3-bS33Y Beta-catenin, respectively. The amplified fragments were cloned into pLVX-Tight-Puro vector and verified by DNA sequencing (see Supporting Information for details). Stable transduced hESC colonies were selected and maintained as previously described [28] . To upregulate E-cadherin expression, the selected colonies were treated with 1 lg/ml of doxycycline. To express bS33Y and EcadDb, the hESCs were treated with 2 lg/ml of doxycycline unless otherwise specified.
Generation of Transgenic Wnt Reporter 7xTCF-eGFP hESCs
Four Wnt reporter hESC sublines (7xTCF-eGFP-EcadDb-Tet-On, 7xTCF-eGFP-bS33Y-Tet-On, 7xTCF-eGFP-vector-Tet-On, and 7xTCF-eGFP) were generated by transduction of the established EcadDb-, bS33Y-, and vector-Tet-On or wild-type hESCs with a 73TCF-eGFP//SV40-PuroR lentiviral vector containing seven Tcf/Lef-binding sites and a puromycin resistance gene (Addgene #24305, a kind gift from Dr. Roel Nusse [44] ). Lentivirus was produced by transient transfection of 293T cells as described previously [45] . Transduced hESCs were selected with puromycin (2 lg/ml) for 14 days. Wnt reporter Tet-OnhESC lines were maintained on drug-resistant DR4 MEF feeder cells in hESC medium supplemented with bFGF (4 ng/ml), 1420 E-Cadherin Tunes Canonical Wnt Signaling in hESCs
STEM CELLS puromycin (1 lg/ml), and G418 (100 lg/ml). All Wnt reporter lines were passaged on Matrigel in MEFCM supplemented with bFGF (12 ng/ml) and puromycin (1 lg/ml) or G418 (100 lg/ml for Tet-On lines) for two passages prior to the Wnt activation assay. The expression levels of TCF-eGFP were determined by flow cytometry.
Flow Cytometry
To 
Real-Time Quantitative PCR and Western Blot
Total RNA extraction, quantitative PCR (Q-PCR), and Western blot were performed as described previously [27] . Forward and reverse primers used in Q-PCR, antibodies used in Western blotting, and additional procedures are described in Supporting Information.
Immunofluorescence Staining, Fluorescence Microscopy, and Image Analysis Experimental methods have been described previously [27, 28] and in Supporting Information.
Other Experimental Procedures
See Supporting Information.
Statistical Analysis
Results are expressed as mean 6 SD. Statistical significance was determined using a Student's t test, ANOVA, or chisquare wherever appropriate. Results were considered significant when p < .05 or <.01.
RESULTS

Short-Term GSK3 Inhibition Temporally Promotes E-Cadherin Expression and hESC Self-Renewal Whereas Long-Term Inhibition Generates Opposing Results
Inhibition of GSK3 has been reported to either promote selfrenewal or induce differentiation of hESCs [2, 14, 46] . We speculated that the dual role of GSK3 inhibition might be time-dependent and controlled by undefined mechanisms. Consistent with our hypothesis, brief inhibition of GSK3 with BIO for 6 hours caused hESC colonies to change from thin and flat to thick and compact morphology with sharp boundaries and hard-to-distinguish individual cells (characteristics of undifferentiated colonies) when observed 24 hours later after the removal of BIO (Fig. 1A) . Notably, gene and protein expression levels of E-cadherin, Nanog, and Oct3/4 were elevated (Supporting Information Fig. S1A , S1B, and Fig. 1B-1E) , and E-cadherin protein on the cell membrane was enriched (Fig. 1B, 1C , immunocytochemistry; Fig. 1F , 1G, flow cytometry) after short-term BIO treatment. Using clonogenic assays, a crucial method to assess ESC self-renewal by reseeding an equal number of single hESCs in each group, we observed an approximately eightfold increase in total clonogenic capacity after short-term BIO treatment (3-fold increase in clonogenic assays 3 2.6-fold increase in total cell number after removal of BIO and continual culture for 4 days, Fig. 1H, 1I ). It can be concluded that short-term BIO treatment enhances E-cadherin expression on the cell membrane and promotes hESC selfrenewal. Next, to address whether prolonged inhibition of GSK3 suppresses E-cadherin expression and promotes differentiation, we examined hESCs after treatment with BIO for 6 hours (short-term) and 4 days (long-term), respectively. In contrast to short-term BIO treatment, long-term BIO treatment markedly reduced Oct3/4 and E-cadherin protein levels ( Fig. 1D-1G ), and significantly downregulated pluripotency transcripts Nanog, Oct3/4, and Sox2 (Fig. 1J) .
Consistent with the above observations, Mixl1 and Brachyury transcripts (primitive streak/mesoderm markers) were significantly upregulated after 4 days BIO treatment while remaining unchanged after 6 hours treatment (Fig. 1K ). Western blot confirmed that long-term BIO treatment resulted in differentiation of hESCs, as indicated by a significant downregulation of Nanog and E-cadherin, and upregulation of Brachyury protein levels (Fig. 1L) . Specifically, Wnt reporter TCFeGFP was not expressed after treatment with BIO for 6 hours but significantly upregulated after 4 days (Fig. 1M-1O) . Thus, the opposing results in response to short-and long-term BIO treatment indicate a time-dependent manner of Wnt signaling pathway in the regulation of hESC self-renewal versus differentiation. Similar results were also obtained by activating Wnt signaling pathway using GSK3 inhibitor CHIR99021 (Supporting Information Fig. S2 ). Collectively, these data illustrate that short-term GSK3 inhibition enhances E-cadherin expression on the cell membrane and hESC self-renewal whereas long-term inhibition results in opposite outcomes.
Dual Function of b-Catenin in Canonical Wnt Signaling Pathway Is Responsible for hESC Self-Renewal and Differentiation
Effects of GSK3 inhibition could be complicated by the diverse cellular activities of GSK3 (downstream of BIO and CHIR99021), which involves transcription, translation, cell cycle, metabolism, antiapoptosis, and signal transduction [47] . To exclude possible nonspecific activity of GSK3, we used recombinant protein Wnt3a and obtained similar results (Supporting Information Figs. S3, S4). As b-catenin is well recognized as the pivotal downstream effector of the Wnt signaling, we decided to examine b-catenin to further study the discrepancy of Wnt signaling pathway on hESC selfrenewal and differentiation. To controllable over-expression of b-catenin in hESCs, we generated a stable hESC line using a tetracycline-inducible lentiviral expression vector that expresses a nondegradable b-catenin mutant bS33Y [41] . A previous study has demonstrated that this mutant is functionally identical to b-catenin, but undegradable due to the substitution of a specific residue that is normally phosphorylated by GSK3b, and therefore is able to activate TCF transcription [41] . 
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Notably, after short-term bS33Y expression, the increased levels of b-catenin and Nanog proteins (data not shown), and an enhanced self-renewal capacity (clonogenic assays), were observed ( Fig. 2A) . These results further confirm that b-catenin signaling is involved in hESC self-renewal. Conversely, long-term (4-6 days) expression of bS33Y led to an increase in total cytoplasmic b-catenin protein and a loss of Nanog expression in a doxycycline dosage-dependent manner (Fig. 2B, 2C ). Significantly, after long-term expression of bS33Y with a high dosage of doxycycline, approximately 30% of colonies exhibited lower levels of Nanog and some cells completely lost Nanog expression together with accumulated b-catenin in the nuclei (Fig. 2D , right panel), indicative of a differentiation property of hESCs due to the prolonged Wnt/b-catenin activation. Consistently, after long-term expression of bS33Y, clonogenic assays revealed a dosedependent impairment in hESC self-renewal (Fig. 2E) , and Western blotting showed diminished Nanog expression (Fig. 2F) . Specifically, following an increase in TCF-eGFP activity, E-cadherin expression on the cell membrane was decreased in a doxycycline dosage-dependent manner ( Fig. 2G-2J ). Together, these findings demonstrate that depending on the duration of Wnt activation, b-catenin has dual function in the control of hESC self-renewal versus differentiation through yet to be determined mechanisms.
Short-Term Upregulation of b-Catenin Enhances hESC Self-Renewal Through E-Cadherin-Associated PI3K/Akt Activation
To investigate how b-catenin enhances hESC self-renewal, we examined the relationship between b-catenin and the adhesion molecule E-cadherin. Several groups, including ours, have recently shown that E-cadherin plays an essential role in the maintenance of hESCs [26] [27] [28] [29] [30] , and in the reprogramming of somatic cells [31] [32] [33] [34] . Our previous study also suggested that inadequate formation of E-cadherin-mediated cell-cell contacts in hESCs hampered clonogenic capacity and self-renewal of hESCs [27, 28] . Since Wnt signaling has been shown to drive an epithelial-tomesenchymal transition [48] , one may speculate that even transient Wnt activation would repress E-cadherin in hESCs.
To address this issue, we simultaneously assessed Wnt reporter TCF-eGFP activity and E-cadherin expression in hESCs using flow cytometry. Significantly, while the levels of Ecadherin transcript and protein were increased, and Ecadherin on the cell membrane was enriched (both percentage and median fluorescence intensity) after treatment with BIO, CHIR99021, or Wnt3a for 6 hours (Figs. 1, 4D-scrambled 1 CHIR99021, Supporting Information Figs. S1-S4), the TCF-eGFP expression was not elevated. This suggests that short-term Wnt activation in hESCs leads to limited functional interaction of b-catenin and TCF in the nucleus. In contrast, long-term Wnt activation resulted in a significant increase in TCF-eGFP reporter activity, which was inversely correlated with the E-cadherin downregulation (Fig. 1 , Supporting Information Figs. S2, S4). It is apparent that short-term upregulation of b-catenin in hESCs mainly promotes E-cadherin expression on the cell membrane (as an intracellular adaptor protein for E-cadherin) but not Wnt signaling in the nucleus.
To further elaborate whether E-cadherin is involved in hESC self-renewal, we subsequently over-expressed E-cadherin in hESCs using a tetracycline-inducible lentiviral vector [28] , and observed an increase in the expression of Nanog and Oct3/4 transcripts, formation of thick compact colonies with more than a fivefold increase in cell density, and enriched junctional E-cadherin expression at cell-cell contacts (Fig. 3A-3C ). We then asked whether loss of E-cadherin results in a decline of hESC self-renewal. Indeed, siRNA targeted Ecadherin knockdown significantly inhibited Nanog and Oct3/4 expression and impaired clonogenic capacity (Fig. 3D, 3E ). Finally, we demonstrated that E-cadherin knockdown also abrogated short-term GSK3 inhibition-induced upregulation of Nanog and Oct3/4 expression (Supporting Information Fig.  S5 ). Collectively, the above results suggest that short-term Wnt/b-catenin activation enhances hESC self-renewal through the augmentation of E-cadherin expression.
To examine the underlying mechanism between Ecadherin expression and hESC self-renewal, we tested the effect of E-cadherin-targeted knockdown on PI3K/Akt activation. It has been documented that PI3K/Akt signaling enhances the expression of pluripotency genes and antagonizes hESC differentiation induced by over-activation of Erk and Wnt signaling [14, 49] . Significantly, E-cadherin knockdown in hESCs resulted in a reduction of Akt activation via decreased Akt phosphorylation on Ser473, indicative of reduced PI3K/Akt signaling (Fig. 4A) . Conversely, E-cadherin upregulation led to an increase in PI3K/Akt activation ( Fig. 4B ) and clonogenic capacity in hESCs (Fig. 4C) , while inhibition of PI3K/Akt abrogated the enhanced clonogenic capacity (Fig. 4C ) and elevated Nanog and Oct3/4 expression induced by E-cadherin upregulation (Supporting Information Fig. S5 ). Specifically, short-term GSK3 inhibition-induced upregulation of E-cadherin protein, Akt phosphorylation, and Nanog and Oct3/4 transcripts was abolished by E-cadherin knockdown, but restored by a specific Akt activator SC79 (Fig. 4D, Supporting Information Fig. S5 ). Furthermore, similar to E-cadherin knockdown, Akt suppression blocked short-term GSK3 inhibition-induced upregulation of Nanog and Oct3/4 transcripts (Supporting Information Fig.   Figure 1 . Short-term GSK3 inhibition temporally promotes E-cadherin expression and human embryonic stem cell (hESC) self-renewal whereas long-term inhibition generates opposite results. (A-L): hESCs were treated with either vehicle (Veh) or BIO for 6 hours. Twentyfour hours after removal of BIO, hESCs exhibit thick and compact colonies (A, bright-field images) that express higher levels of Ecadherin (E-cad), Nanog, and Oct3/4 (B and D, immunofluorescence staining; C and E, quantitative image analysis of fluorescence intensity, n > 100 from three independent experiments for each group; F and G, flow cytometry). They also show high cloning efficiency (H, clonogenic assays, n 5 3). After removal of BIO and continual culture for 4 days, BIO treatment leads to a high cell yield (I). S5). Taken together, these data demonstrate that short-term Wnt/b-catenin activation enhances hESCs self-renewal through E-cadherin upregulation that is associated with PI3K/Akt activation.
E-Cadherin Sequesters b-Catenin to Suppress Wnt-Induced hESC Differentiation
While E-cadherin has recently been revealed as an important component in hESC self-renewal [26] [27] [28] [29] [30] , its regulatory role in Wnt/b-catenin signaling in ESCs remains undefined. It is known that cytoplasmic b-catenin can either be phosphorylated by GSK3b which led to its degradation, or bound by E-cadherin intracellular domain through direct protein-protein interactions at the cell-cell junctions. In either fate, accumulation of free cytoplasmic b-catenin will be minimized, thus preventing translocation of b-catenin into the nucleus to initiate expression of targeted downstream genes through interaction with the LEF/ TCF complex [18, 50] . The lack of nuclear shift of b-catenin and TCF-eGFP reporter activity in undifferentiated hESCs (Fig. 2B,  2D , 2G, 2H, DOX-untreated group) prompted us to propose that, in addition to association with PI3K/Akt activation to regulate hESC self-renewal and differentiation, E-cadherin also influences Wnt signaling by sequestering b-catenin.
To determine whether disruption of interaction between E-cadherin and b-catenin impairs hESC self-renewal, we transfected hESCs with a truncated E-cadherin that lacks the b-catenin-binding domain (EcadDb [39] ) in combination with other genes. Stappert and Kemler [40] have shown that EcadDb mutant allows more cytoplasmic b-catenin to enter the nucleus and interact with LEF/TCF complex. Particularly, ectopic coexpression of bS33Y and EcadDb, but not coexpression of bS33Y and wild-type E-cadherin, led to a significant downregulation of pluripotency genes Nanog, Oct3/4, and Sox2 (Fig. 5A) . However, this effect was rescued by coexpression of bS33Y with wild-type E-cadherin instead of EcadDb (Fig. 5A) , demonstrating that the repressed expression of pluripotency genes after Wnt activation relies on the b-cateninbinding ability of E-cadherin. Importantly, the Brachyury transcript was also significantly upregulated in comparison to controls after short-term ectopic coexpression of bS33Y and EcadDb (Fig. 5B) . These results suggest that mutating the b-catenin binding domain of E-cadherin abrogates self-renewal enhanced by short-term Wnt activation (as shown in Fig. 1 ) and sensitizes hESCs to Wnt-induced differentiation.
To further confirm the above observation, we generated a stable hESC line using a tetracycline-inducible lentiviral expression vector to control EcadDb expression using EcadDb plasmid [39] . It is known that accumulation of b-catenin that is specifically unphosphorylated at GSK3b sites is critical for b-catenin/TCF-mediated transcription [51] . We therefore used a monoclonal antibody to detect the transcriptionally active form of b-catenin (active b-catenin), which recognizes the signaling form of b-catenin specifically unphosphorylated at S37 and T41 [51, 52] . In comparison to untreated control, we observed an increase in nuclear-localized active b-catenin when EcadDb expression was induced by the addition of doxycycline alone for 4 days (Fig 5C-5E ), indicative of a state of Wnt/b-catenin signaling activation. Importantly, DOX-induced EcadDb over-expression plus Wnt3a stimulation led to a further increase in the nuclear accumulation of active b-catenin and high-level expressions of Brachyury and Mixl1 (Fig. 5C-5F ). This suggests that hESCs expressing EcadDb without bcatenin-binding domain are more sensitive to Wnt/b-catenin activation, resulting in early differentiation. To quantify the extent by which hESC differentiation is dependent on functional interactions between E-cadherin and b-catenin, we cultured EcadDb-Tet-On hESCs in the presence or absence of Wnt3a for 4 days, then performed clonogenic assays and measured the numbers and intensity of alkaline phosphatase-positive (AP1) colonies. Again, after addition of both Wnt3a (activation of Wnt signaling) and DOX (induction of EcadDb expression), differentiation was significantly enhanced based on the loss of AP staining and gain of Brachyury and Mixl1 expression (Fig. 5F -5H, AP1 colonies: Wnt3a alone vs. DOX1Wnt3a, 43% 6 5% vs. 11% 6 6%). As such, in addition to its association with PI3K/Akt activation, Ecadherin serves as b-catenin sink to delay hESC differentiation in response to prolonged Wnt activation.
We finally asked whether introducing EcadDb into hESCs enhances functional interaction of b-catenin and TCF if Ecadherin truly acts to sequester b-catenin away from cytoplasm and TCF. Indeed, after being treated with DOX alone for 4 days, both percentage of TCF-eGFP-positive cells and median fluorescence intensity were increased up to five-to sevenfold in comparison to DOX-untreated cells (Fig. 6A [fluorescence microscopy], 6B-6D [flow cytometry]), demonstrating that E-cadherin is capable of minimizing nuclear b-catenin-TCF signaling. Consistently, EcadDb hESCs were also more sensitive to Wnt3a treatment, exhibiting an early TCF activation and greater TCF-eGFP reporter activity than control groups (Fig. 6A-6D) . Collectively, it can be concluded that E-cadherin sequesters b-catenin to suppress its nuclear localization and functional interaction with TCF.
Interestingly, hESC differentiation progressed even after removing BIO at day 4 and cultivating in conventional conditions supporting self-renewal, indicating that hESC differentiation induced by prolonged Wnt/b-catenin activation is irreversible. This prompted us to examine the regulatory circuits associated with Wnt and E-cadherin that switch hESCs from self-renewal to definite differentiation.
b-Catenin-Induced Slug Upregulation Reinforces hESC Differentiation by Downregulating E-Cadherin and Upregulating Brachyury
Nuclear transactivation of b-catenin has been shown to upregulate expression of E-cadherin suppressor genes Snail and Slug in other cell types to initiate epithelial-mesenchymal transition [1, 21, 53] . While b-catenin/TCF transcription-dependent andindependent in the control of ESC self-renewal have been well studied, little is known about the crosstalk between Wnt/b-catenin, Snail/Slug, and E-cadherin in ESC fate decision. Because interaction between E-cadherin and b-catenin at cell-cell junctions favors hESC self-renewal (Figs. 3-6) , we propose the ) after E-cadherin upregulation. E-cadherin-Tet-On hESCs were treated with DOX (2 mg/ml) for 48 hours, followed by Western blot analysis. (C): Inhibition of PI3/Akt with LY294002 abrogates the enhanced clonogenic capacity induced by E-cadherin upregulation. E-cadherin-Tet-On hESCs were treated with or without DOX (2 mg/ml) in the presence or absence of LY294002 (5 mM) for 24 hours, followed by clonogenic assays (n 5 3). (D): Ecadherin knockdown abolishes short-term GSK3 inhibition-induced upregulation of E-cadherin and phosphorylated Akt, while specific Akt activator SC79 counteracts the effect of E-cadherin knockdown. After siRNA knockdown for 44 hours, hESCs (H9 and H1 lines) were treated with either CHIR99021 (6 mM) or vehicle (DMSO) for 6 hours, followed by Akt inhibitor VIII (6 mM), or Akt activator II SC79 (6 mg/ml), or vehicle for an additional 30 minutes. All data in this figure are mean 6 SD and were generated from H1 and H9 lines. **, p < .01. balance between self-renewal and differentiation in response to Wnt/b-catenin signaling is coordinated by a two-layer circuit: (a) interaction between E-cadherin and b-catenin at cell membrane, and (b) crosstalk among E-cadherin, Snail/Slug, and Wnt/ b-catenin pathway as determined below. We first asked to what extent Snail or Slug was involved in Wnt/b-catenin signaling in the control of hESC self-renewal and differentiation. We found that Slug but not Snail transcript was increased significantly in a timely manner after 1 day BIO treatment and further upregulated in both transcript and protein levels after 4 days BIO treatment (Fig. 7A, 7B) . Despite the initial increase of Snail protein in hESCs after short-term Wnt activation, unexpectedly, neither Snail protein nor its transcript was significantly augmented in comparison to Slug after long-term Wnt activation (Fig. 7A, 7B ), suggesting that Slug is predominantly involved in the Wnt/b-catenin pathway in hESCs.
We next examined how a crosstalk between E-cadherin and b-catenin influences Slug expression in hESCs. Ectopic coexpression of bS33Y and EcadDb (which lacks the b-catenin binding domain), but not coexpression of bS33Y and wild-type E-cadherin, led to upregulation of Slug expression (Fig. 7C) and downregulation of pluripotency genes Nanog, Oct3/4, and Sox2 in hESCs (Fig. 5A ). This suggests that loss of a bcatenin-binding domain in E-cadherin promotes Slug expression and impairs hESC self-renewal. Consistently, ectopic expression of EcadDb mutant in response to short-term Wnt3a treatment further augmented Slug expression in hESCs (Fig. 7D) . Comparable results were observed in a Tet-On stable hESC cell line expressing EcadDb after short-term Wnt3a treatment as well (data not shown). These findings demonstrate that E-cadherin and b-catenin work together to regulate Slug expression after Wnt activation in hESCs.
We then asked whether Slug plays a potent role in the control of hESC self-renewal and differentiation in response to Wnt signaling. To address this, we carried out transient knockdown of Slug using pLKO-siSlug (Fig. 7E) [42] . Suppression of Slug followed by long-term BIO treatment for 4 days resulted in a significant decrease of differentiation marker Brachyury (Fig. 7F, 7G) , and an increase in clonogenic capacity in comparison to scrambled control (Fig. 7H) , indicating that Slug inhibition has an adverse effect on hESC differentiation after upregulation of Wnt signaling. Taken together, the above data provide the first evidence that loss of E-cadherin b-cateninbinding domain or long-term Wnt/b-catenin activation upregulates Slug expression, which reinforces hESC differentiation.
DISCUSSION
The disparate effects of Wnt/b-catenin signaling pathway on ESC self-renewal, differentiation, and lineage commitment are not fully understood. In this study, we demonstrate that the seemingly controversial biological roles of Wnt pathway in hESCs are largely time-dependent and regulated by a twolayer circuit. Short-term activation of Wnt/b-catenin signaling temporally enhances hESC self-renewal via upregulating Ecadherin expression at cell-cell junctions (the first layer), leading to PI3K/Akt activation. Enhanced E-cadherin expression also serves as a "sink" to reduce the accumulation of free cytoplasmic b-catenin in favor of hESC self-renewal. Conversely, long-term activation of Wnt/b-catenin signaling increases free cytoplasmic b-catenin that exceeds the binding capacity of E-cadherin, leading to translocation of b-catenin into the nucleus and upregulation of E-cadherin suppressor Slug expression. The upregulated Slug, but not Snail, in turn inhibits E-cadherin expression and reinforces the accumulation of b-catenin (the second layer), which leads to definitive differentiation of hESCs (working model, Fig. 7I ).
The potential role of cell-cell adhesion molecules in the regulation of Wnt/b-catenin signaling pathway in ESCs has been speculated but not well documented, mainly due to the early demonstration of E-cadherin as an unnecessary component in mouse ESC self-renewal [24] . As a result, the majority of studies regarding Wnt/b-catenin signaling in ESCs are focused on its nuclear regulation via TCF transcriptional factors [1, 36, 54] or TCF-independent functions through interaction with Oct3/4 [13, 55] . Current opposing observations regarding endogenous Wnt signaling in hESC self-renewal versus differentiation further complicate this debate [8, 56] , although we did not observe significant changes after inhibition of endogenous Wnt ligands' secretion with IWP2 (Supporting Information Fig. S2 ). Recent findings on the important role of E-cadherin in ESCs [25] [26] [27] [28] [29] [30] 35] prompted us to investigate whether and how E-cadherin and its associated molecules regulate Wnt/b-catenin signaling pathway in ESCs.
Human ESCs provide a unique system to address this question because their self-renewal is highly dependent on Ecadherin expression. Interestingly, a recent report has suggested that retention of stabilized b-catenin in the cytoplasm maintains self-renewal of pluripotent stem cells [57] . Here, we demonstrate that temporal hESC self-renewal in response to short-term b-catenin activation is dependent on E-cadherin (Figs.  3, 4) . Considerable studies have shown that PI3K/Akt pathway is specifically responsible for ESC self-renewal [14, 49, 58, 59] . Our findings provide the first evidence that links E-cadherinmediated cell-cell adhesion to PI3K/Akt activation in hESC self-renewal.
In addition, we also provide the first demonstration that Wnt signaling-induced hESC differentiation can be suppressed by cell-cell adhesion molecule E-cadherin. One underlying mechanism is via E-cadherin intracellular domain that sequesters free cytoplasmic b-catenin (Fig. 5) . It is possible that other mechanisms may also come into play given the widearray of E-cadherin and Wnt functions and cell typedependencies, which warrants further investigation in human pluripotent stem cells. For instance, in mouse ESCs, there is negligible transcriptional activation of b-catenin during selfrenewal. b-Catenin forms a complex with Oct3/4 and Ecadherin in the membrane and it is this complex that is involved in regulating mESC self-renewal and differentiation [60, 61] . In cancer cells, E-cadherin enhances the interaction between caveolin-1 and b-catenin near the cell membrane thereby reducing b-catenin and TCF/LEF-dependent transcription [62] . E-Cadherin-mediated cell-cell adhesion may also enhance the turnover of cytoplasmic b-catenin by promoting the activity of a b-catenin phospho-destruction complex located near adhesion junctions [63] . Conversely, unligated Ecadherin initiates Wnt signaling since stabilization of Ecadherin-mediated cell-cell junctions (i.e., formation of Ecadherin-p120-catenin complex) inhibits the assembly of the Wnt signalosome [63] .
One unexpected finding in our study is the involvement of E-cadherin suppressor Slug but not Snail in reinforcing the switch of hESCs from self-renewal to differentiation in response to Wnt/b-catenin signaling. Although Snail protein Information Fig. S7 ).
was temporarily increased after short-term Wnt/b-catenin activation (Fig. 7B) , hESCs retained self-renewal properties with increased clonogenicity (Fig. 1H) . In contrast, Slug was upregulated after 1 day Wnt/b-catenin activation and further increased thereafter (Fig. 7A, 7B) . A similar trend was also observed when EcadDb mutant (lack of b-catenin binding capacity) was over-expressed after short-term activation of Wnt signaling pathway (Fig. 7C, 7D) . Furthermore, transient knockdown of Slug was capable of abrogating long-term Wnt activation-induced high level Brachyury expression, low level E-cadherin expression, and poor clonogenic capacity (Fig. 7F-7H ). These data suggest that increasing Slug expression represents a turning point in the fate decision of hESC self-renewal versus differentiation. TCF1, TCF3, and TCF4 binding sites in Slug promoter have recently been revealed by Chip-seq in several human cancer cell lines (ENCODE Consortium). Therefore, it is possible that E-cadherin indirectly suppresses Slug expression by sequestering b-catenin and reducing its effect on TCFs/Slug. Although the direct connection between Slug and Brachyury is unclear, Brachyury has been shown to bind to the Ecadherin promoter, and over-expression of Brachyury resulted in downregulation of E-cadherin and upregulation of Slug in epithelial tumor cells [64] . It is possible that high levels of Brachyury and Slug expression after long-term Wnt activation further suppress E-cadherin expression, thereby skewing the balance from self-renewal to differentiation. Our proposed working model (Fig. 7I) , which includes Wnt/b-catenin, E-cadherin, PI3K/Akt, and Slug, provides a mechanistic insight underlying the dynamic regulation between self-renewal and differentiation in hESCs. To date, several signaling pathways have been shown to significantly influence ESC fate, including PI3K, Wnt, Activin A/Smad2,3, and Raf/Mek/Erk pathways [65] . Recently, Singh et al. proposed the existence of a signaling network crosstalk in hESCs, which involves PI3K/Akt suppressing Erk and Wnt signaling to allow Smad2/3 to activate a specific subset of target genes required for self-renewal [14] . Our results further expand the current working model by revealing a new regulatory network comprising of b-catenin, E-cadherin, PI3K, and Slug in hESCs. Since b-catenin collaborates with Smad2/3 to induce mesendoderm gene expression [14] , it is possible that E-cadherin could indirectly affect Smad2/3 pathway through reducing cytoplasmic-free b-catenin. As Mek/Erk signaling has been shown to be downregulated by E-cadherin-dependent PI3K/ Akt pathway in differentiating intestinal epithelial cells [66] , Ecadherin-associated PI3K activation may also contribute to the inhibition of Erk pathway to reduce hESC differentiation.
CONCLUSIONS
In summary, this study provides direct evidence, for the first time, that integrates b-catenin, the cell-cell adhesion molecule E-cadherin, PI3K/Akt, and Slug into the current signaling network in the control of cell fate of pluripotent stem cells. Our work shows how E-cadherin and Slug actively tunes Wnt signaling pathway and also provides a unique tool to controllably promote hESC self-renewal by short-term Wnt activation. In addition, these findings may shed light on the dual-role of canonical Wnt signaling in developmental and cancer biology.
